Apr 26, 2016

Posted by in Stock Reports | 0 Comments

Insiders Accumulating Significant Shares: Eli Lilly and Co (NYSE:LLY), Novartis AG (ADR) (NYSE:NVS), Monsanto Company (NYSE:MON)

Insiders Accumulating Significant Shares: Eli Lilly and Co (NYSE:LLY), Novartis AG (ADR) (NYSE:NVS), Monsanto Company (NYSE:MON)

Insider Trading is the buying or selling of a security by someone who has access to material, nonpublic information about the security. Insider trading is legal once the material information has been made public, at which time the insider has no direct advantage over other investors. The SEC, however, still requires all insiders to report all their transactions. So, as insiders have an insight into the workings of their company, it may be wise for an investor to look at these reports to see how insiders are legally trading their stock.

It isn’t a coincidence that corporate executives seem to always buy and sell at the right times. After all, the CEOs and CFOs of the world have access to every bit of company information you could ever want. This kind of information is extremely valuable to individual investors. For example, if insiders are buying shares in their own companies, they usually know something that normal investors do not. They might buy because they see great potential, a merger, acquisition or simply because they think their stock is undervalued.

Moving on to the first insider trade Apr 12, 2016 which involved LILLY ELI & CO, a 10% Owner at Eli Lilly and Co (NYSE:LLY), who acquired 500,000 shares at $10.00 per share to put the total holding at 2,568,543 shares. Its shares currently owned by company management are 11.80% while institutional investors own about 77.60%. The 6-month change recorded in total insider ownership was -0.99%. On the other side, 0.19% change in total institutional ownership has been reported for the 3-month period.

Novartis AG (ADR) (NYSE:NVS) saw an insider buy stock in the company on Apr 03. Novartis Bioventures Ltd, 10% Owner of the company, bought 300,000 shares for $10.00 per share worth a total of $3,000,000. After this insider buying, Novartis Bioventures Ltd now has a total stake of 2,310,924 shares in the company. Its shares currently owned by company management are 9.30% while institutional investors own about 9.80%. The 6-month change recorded in total insider ownership was 0.27%. On the other side, -0.01% change in total institutional ownership has been reported for the 3-month period.

Monsanto Company (NYSE:MON) also received some insider trading action as POSTE GEORGE, who is the company’s director added some 1,136 shares at a price of $91.93 per share to the holding that now comprises of 34,619 shares. Its shares currently owned by company management are 0.30% while institutional investors own about 85.10%. The 6-month change recorded in total insider ownership was -1.33%. On the other side, -0.16% change in total institutional ownership has been reported for the 3-month period.

 

 

 

 

 

Comments are closed.